Firm Analyst
Barclays Capital   Jim Birchenough
Boenning & Scattergood   Debjit Chattopadhyay
Credit Suisse   Michael Aberman
Merriman Curhan Ford   Joe Pantginis
Morgan Stanley   Steven Harr
Needham   Mark Monane
Piper Jaffray   Edward A. Tenthoff
RBC Capital Markets   Michael Yee
Robert W. Baird & Co   Christopher J. Raymond
ThinkEquity   Jason Kolbert
Standard & Poors   Steven Silver

Regeneron Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Regeneron Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Regeneron Pharmaceuticals, Inc. or its management. Regeneron Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Print Print page     Email Email page

Stock Information

NASDAQ:REGN
$25.50   - 0.28
Mar 11, 2010
4:00 PM ET
Quotes delay at least 20min., by eSignal.
Stock price graph
3 Mo.   6 Mo.   1 Yr.

Shareholder Tools

Featured Report